A device worn on the leg to help treat bowel issues in people with spinal cord injuries
AccelBand, a leg-worn transcutaneous neuromodulation device for treating neurogenic bowel dysfunction in individuals with spinal cord injury
['FUNDING_OTHER'] · TRANSTIMULATION RESEARCH, INC. · NIH-10703441
This study is testing a wearable device that gently stimulates nerves in the leg to help improve bowel function for people with bowel issues caused by spinal cord injuries, offering a more comfortable and effective option for managing their condition.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TRANSTIMULATION RESEARCH, INC. (nih funded) |
| Locations | 1 site (OKLAHOMA CITY, UNITED STATES) |
| Trial ID | NIH-10703441 on ClinicalTrials.gov |
What this research studies
This research investigates the use of a leg-worn device that applies transcutaneous neuromodulation to improve bowel function in individuals with neurogenic bowel dysfunction due to spinal cord injury. The device targets specific acupuncture points to stimulate nerves that control bowel movements, aiming to enhance colonic motility and rectal sensitivity. By exploring this non-drug therapy, the research seeks to provide a dignified and effective alternative to current bowel care practices that many patients find burdensome. Participants will be monitored for improvements in bowel function and quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with spinal cord injuries who experience neurogenic bowel dysfunction.
Not a fit: Patients without spinal cord injuries or those who do not experience bowel dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve bowel function and quality of life for individuals with spinal cord injuries.
How similar studies have performed: Previous studies have shown promising results with transcutaneous neuromodulation for similar bowel dysfunctions, indicating potential for success in this novel application.
Where this research is happening
OKLAHOMA CITY, UNITED STATES
- TRANSTIMULATION RESEARCH, INC. — OKLAHOMA CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PIKOV, VICTOR — TRANSTIMULATION RESEARCH, INC.
- Study coordinator: PIKOV, VICTOR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.